Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
about
Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c miceProtein crystallography and infectious diseases.Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.Generation of female genital tract antibody responses by local or central (common) mucosal immunizationProtective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxinImmune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodesNasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in miceSerum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responsesLimited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartmentsMonoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines.Oral microbial ecology and the role of salivary immunoglobulin ARole of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine.Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.Nasal immunization with homogenate and peptide antigens induces protective immunity against Trichinella spiralisTrachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.Vaccines against gonorrhea: current status and future challenges.Immunopathogenesis of recurrent vulvovaginal candidiasis.Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.Enhancement of anti-Shigella lipopolysaccharide (LPS) response by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2a LPS vaccinesPolymyxins as novel and safe mucosal adjuvants to induce humoral immune responses in mice.Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxinsLymphotoxin plays a crucial role in the development and function of nasal-associated lymphoid tissue through regulation of chemokines and peripheral node addressin.A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvantInduction of common mucosal immunity by hormonally immunomodulated peripheral immunizationSalivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
P2860
Q23071101-96C6F1DE-F1AF-4F00-94EF-65AD23A39098Q30419162-4ADD8DF4-69DE-4C14-95C8-18EAD27D8EC2Q33591055-E7E52458-A884-4C71-BE91-5CC8A801CBE9Q33591251-AF2AED1C-DDE1-4E6B-B7D3-FBC6F3D8CD92Q33596220-886F3A42-F3F3-4253-A79D-46E597F05E8EQ33597587-6FBFED74-C0D9-46BA-8D6F-16F7344CBFB9Q33599589-E86CB8EA-748F-4C3E-A39D-231C9D6B9B9BQ33618911-B1BADA5C-DEB8-4838-9D1E-F3B30E68E3E9Q33788861-5CCADD70-D1A2-4AA5-9A64-1075EE1E18CAQ33822614-7CADABAB-BD0D-4266-94EB-2FB8B73FDB8AQ33852342-C2770604-7729-4B1E-A2D5-6D59744590BBQ33883543-30585C61-C107-4933-AB9B-E67C7B6D295EQ34000146-35BC3BED-CB31-4692-9EAA-9C842E1410EAQ34000204-914A408D-5D5C-4D87-B190-14E7E9FF13A8Q34001388-68CDA0F4-071F-45AC-A75D-C061B1E34169Q34003291-E4B19267-D2A2-42B4-B521-D45E27832D48Q34003394-7D76EF33-D199-4A29-8606-9AD8A6A92F28Q34003768-23084EDD-52CE-4839-B085-4FA0C80F202FQ34006385-EC210C52-7EFF-4C06-870A-D7874A763279Q34006720-1627E024-DDAB-49F2-83D9-2CD883BC58AEQ34008465-FCF46341-B9BB-4F26-9BE2-ACD23F53E0F1Q34009973-808198E1-FA6F-4767-A303-B9F3D63ACAD4Q34021831-01A2FC58-FF6B-46B2-85B1-185EFF0C9923Q34126807-615AAE4F-E62F-400D-BA0F-A95BED32B8BFQ34222728-C88EB60C-E0F3-4DBE-B5F9-6ACA27AD0E1FQ34258467-66525A9C-8537-459B-A337-D49B8685897DQ34353473-405424E4-4D41-4919-9B6A-5D38432628E2Q34369729-FA265521-6289-45F9-B122-01521F9C4B8CQ34397458-F63A101F-2D2F-4AE8-9F6E-DA934D980621Q34532411-4B82A4BB-1AF2-49B2-9262-1C7559852B43Q34546234-99ACCF9D-19D1-4B7E-94FD-0B2E547A9F8DQ34675017-1D861468-16FF-4BDE-A8EB-CF0667B068FCQ34933032-56B40C01-3303-4680-B3DD-1F7DD78EFC8CQ34972133-BF2914C3-196C-4603-AA3A-F46691365C20Q35083503-33561F78-42B1-459D-BB4F-5E45E12976A6Q35414871-49365EC0-637F-486C-9631-FCCEFD8A01E6Q35434055-B353E9E1-5E67-4EC0-AC66-6BD693313B29Q35476128-1AE02A1A-57E2-4C6E-81F1-B47931E4DB28Q35479003-F679A2C9-016B-416D-B188-A95FA1EE5F5BQ35482140-A4B6DC11-DBF3-47C5-AACD-1BB236184088
P2860
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@ast
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@en
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@nl
type
label
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@ast
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@en
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@nl
prefLabel
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@ast
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@en
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@nl
P2860
P1476
Induction of mucosal immunity ...... h the cholera toxin B subunit.
@en
P2093
P2860
P304
P407
P577
1993-01-01T00:00:00Z